Company Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd
Equities
688336
CNE1000062X2
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22.8 CNY | +4.11% | +1.42% | +1.29% |
Apr. 25 | Sunshine Guojian Pharmaceutical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 21 | Sunshine Guojian Pharmaceutical's Profit Surges Sixfold in 2023 | MT |
Business Summary
Number of employees: 965
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antibody Drugs
100.0
%
| 825 | 100.0 % | 1,014 | 100.0 % | +22.84% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
99.3
%
| 795 | 97.2 % | 1,007 | 99.3 % | +26.66% |
Other Countries
0.7
%
| 23 | 2.8 % | 7 | 0.7 % | -68.50% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 616,785,793 | 81,189,015 ( 13.16 %) | 0 | 13.16 % |
Company contact information
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
399 Libing Road Shanghai Free Trade Zone
201203, Shanghai
+
http://www.3s-guojian.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+1.29% | 1.86B | |
-0.12% | 92.26B | |
-2.63% | 38.11B | |
-12.76% | 32.9B | |
+66.54% | 26.51B | |
-13.02% | 15.75B | |
-5.27% | 13.36B | |
-10.50% | 11.65B | |
-49.11% | 10.12B | |
+187.82% | 9.78B |
- Stock Market
- Equities
- 688336 Stock
- Company Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd